Population Health Management Global Market Report 2023

“Population Health Management Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on population health management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for population health management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The population health management market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

* The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

* The impact of higher inflation in many countries and the resulting spike in interest rates.

* The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Component: Software; Service

• 2) By Mode Of Delivery: On Premise; Cloud-Based

• 3) By End-User: Providers; Payers; Other End-Users

• Companies Mentioned: Allscripts Healthcare LLC; Arcadia; Athenahealth Inc.; Citra Health Solutions; Conifer Health Solutions

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the population health management market are: Allscripts Healthcare LLC, Arcadia, Athenahealth Inc., Citra Health Solutions, Conifer Health Solutions, Cotiviti Inc., Deloitte Touche Tohmatsu Limited, eClinicalWorks, Enli Health Intelligence, Epic Systems Corporation, Evolent Health Inc., Forward Health Group, Koninklijke Philips, Lightbeam Health Solutions, Lumeris Inc., McKesson Corporation, MEDecision Inc., NextGen Healthcare Inc., Optum Inc., Orion Health, IBM Corporation, Accenture plc, Advisory Board, GE Healthcare (General Electric Company), Persivia Inc., RedBrick Health Corporation, Verscend Technologies Inc., and Welltok Inc.

The global population health management market grew from $39.06 billion in 2022 to $47.23 billion in 2023 at a compound annual growth rate (CAGR) of 20.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The population health management market is expected to grow to $99.75 billion in 2027 at a CAGR of 20.5%.

The population health management market includes revenues earned by entities care integration, care coordination, patient engagement, data analytics and health information technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Population health management refers to the process of improving clinical health outcomes of a defined group of individuals through patient engagement and improved care coordination and is supported by financial and care models. The population health management is used to improve the health outcomes of a group by identifying and monitoring patients.

North America was the largest region in the population health management market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population health management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The main components of the population health management market include software and services. Software healthcare management refers to the use of software solutions to facilitate data across healthcare IT systems to improve operational efficiency and promote care delivery. The mode of delivery of population health management solutions includes on-premise and cloud-based. The various end-users include providers, payers, and other end-users.

The rising demand for solutions supporting value-based care delivery by healthcare shareholders is expected to propel the growth of the population health management market going forward. Value-based healthcare is a healthcare delivery framework that encourages healthcare providers to focus on the quality of services rendered as opposed to quantity. Value-based care delivery helps in reducing errors by enhancing workflows and interoperability, and lowers costs while increasing patient satisfaction, allowing executives to monitor and manage care. According to the Healthcare Payment Learning and Action Networks, a US-based group of public and private health care leaders' APM measurement report, 40.9% of US healthcare payments came from value-based reimbursement models in 2020, which is a 2.7% increase over the 2019 rates. Thus, the rising demand for solutions supporting value-based care delivery by healthcare shareholders is driving the population health management market.

Product innovation is a key trend gaining popularity in the population health management market. Major companies operating in population health management are looking for new product development to strengthen their position in the population health management market. For instance, in October 2021, Verana Health, a US-based clinical database provider operating in the population health management market, launched VeraQ, a population health data engine. VeraQ converts unfiltered, raw healthcare data into a unique and actionable real-world data asset, Q data, from which business insights and clinical research can be derived.

In April 2021, Cerner Corporation, a US-based healthcare information technology solutions, services, devices, and hardware provider, acquired Kantar Health for an amount of $375 million. Cerner's real-world data and technology combined with Kantar Health's rich life sciences expertise is expected to accelerate innovation in life sciences research and improve patient outcomes. Kantar Health is a US-based provider of data, analytics, and research to the life sciences industry, operating in the population health management market.

The countries covered in the population health management market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.